Flanders Cynthia sold $1.7M of AGX

Flanders Cynthia sold 2,596 shares of ARGAN INC (AGX) at $666.31 ($1.73M total) on 2026-06-15.

Original reporting
SEC EDGAR · Flanders Cynthia
Published Jun 16, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AGX
Neutral
low confidence
Mentioned
$AGX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AGXNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale size and price ($666.31/share) with holdings after sale (23,144 shares), which may influence short-term sentiment but does not change fundamentals based on the provided text.

02

Market read

Traders may monitor AGX for follow-on insider activity, but the filing alone is unlikely to drive a durable repricing without additional company catalysts.

03

What to watch

Insider sales are common and often not predictive; the article provides no context on prior sales cadence, option exercises, or tax-related selling.

Relevance 6/10Novelty 6/10Timing: filed 2026-06-16; sale dated 2026-06-15

Background

The article is an SEC Form 4 insider transaction disclosure for Argan Inc (AGX).

Company-level read

Ticker impact

$AGXNeutralLow confidence
Context

Argan Inc director Cynthia Flanders sold 2,596 shares in an open-market transaction for about $1.73M, per a new SEC Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

This is a routine Form 4 insider sale with no accompanying company-specific catalyst, guidance, or operational change disclosed in the text.

Market effects

No sector-level read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or liquidity needs; the absence of a stated 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • Argan Inc

    Company whose director sold shares; subject of the Form 4 disclosure.

  • Cynthia Flanders

    Director who executed the open-market sale of 2,596 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AGXMed

Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)

Silver X Mining Corp. (AGX) filed an updated NI 43-101 technical report for its Nueva Recuperada project in Peru, showing increased mineral resources. Measured and Indicated resources total 10.4 Mt with 67.3 Moz AgEq, up 107% from the previous estimate. Inferred resources total 21.6 Mt with 184.3 Moz AgEq. The report includes revisions from the September 22, 2026 news release, with no change in tonnage or classification. The company plans to expand its mining operations and plant capacity.

$AGXMedAI 8/10

Argan’s (AGX) Power Boom Comes With A Margin Catch

Argan (AGX) reported record Q2 revenue of $384.0M (+61.5% YoY) and net income of $53.3M, driven by its Power segment. Gross margin slipped to 19.3%, and backlog decreased to $2.5B. The company is debt-free with $1.03B in cash, returning $51.7M to shareholders. Management expects new projects but faces regulatory challenges and margin compression.

$AGXMed

Argan (AGX) Q2 2027 Earnings Call Transcript

Argan (AGX) reported Q2 2027 revenue of $384.0M, up 61.5%, with net income of $53.3M ($3.76 per diluted share). Power segment revenue grew 53% YoY to $301M, while Industrial segment revenue rose 111% to $76M. Consolidated backlog decreased to $2.5B. The company plans to complete a new fabrication facility in North Carolina by Q3 2027.